CATEGORIES: CMT Update

Now GRIN is Accessible in 141 Different Languages!

by | Mar 9, 2015 | 4 comments

The Global Registry for Inherited Neuropathies (GRIN) has implemented Google Translate.  Why did we choose Google?  Because Google is leading the way in teaching computers how to interpret meaning, avoiding the traditional method of decoding language.

Software that decodes language can turn ‘kindergarten’ into ‘children garden’.  Instead, “Google mines existing translated material, recognizes how words or phrases typically correspond, and uses probability to deliver the best match based on context”.1

Having the ability to communicate with patients in 141 different languages will hopefully result in more patients joining GRIN globally to prepare for future clinical trials, for example, Pharnext’s PXT-3003 phase III clinical trials for later this year.

1Ref: https://translate.google.com/

Learn more on this topic

Related Blog Posts

Building Awareness on CMT and Supporting the Patient Community – HNF Announces Support from Pharnext

HNFpharnext recently entered into a partnership with the French biopharmaceutical company, Pharnext, to help raise awareness of Charcot-Marie-Tooth (CMT) disease and support the CMT patient community through several initiatives. Building awareness is key! Pharnext’s support will assist HNF in distributing HNF’s CMT Update quarterly newsletter, enhancing the Global Registry for Inherited Neuropathies (GRIN), setting up activities for CMT September Awareness Month in the US and strengthening the CMT Inspire Community.

In Memoriam

The HNF family has lost two great people this summer: Franklin G. Downing Sr. (father of board member Matthew Downing) and George G. Gatta (father of board member Kathleen Zappola).

Targeting PMP22 in CMT1A Patients with Gene Duplication

In previous collaborative work with a group of investigators including Dr Rolf Renne from the University of Florida, Dr. Alex Murashov from East Carolina University and Dr. Lynn Hudson from the NIH-NINDS, we validated a microRNA known as miR29a as a reagent that corrected the expression level of PMP22 in rodent Schwann cells.

Join the conversation

Leave a Comment

4 Comments

  1. Mahmoud abdelazim

    I suffering from cmt “hereditary motor neuropathy”
    I hope to join research and clinical trials

    Reply
  2. Lesa

    I have CMT in my hips legs and feet. Most of my mother’s side of the family has cmt and my grandmother’s side of family.

    Reply

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news